Christopher O. Audu
Rating: 5.0 of 5
( out of 30 reviews )

Christopher O. Audu, MD, PhD

Languages spoken: English

Clinical Locations

Primary Location

University of Utah Hospital

Vascular Surgery
50 N Medical Dr
Salt Lake City , UT 84132
801-585-7676
Get Directions

Primary Children's Hospital

Pediatric Vascular Surgery
100 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-581-3495
Get Directions

  • Christopher Audu MD, PhD, is an integrated residency-trained, adult and pediatric surgeon-scientist specializing in vascular surgery, medicinal chemistry, biophysical chemistry, immunology, and drug development as it relates to vascular disease and pathophysiology.

    Dr. Audu’s Clinical and Surgical Specialties Include:

    • Cerebrovascular disease
    • Upper extremity arterial and venous disease
    • Aortic pathology
    • Visceral artery disease
    • Aortoiliac occlusive disease
    • Peripheral arterial disease
    • Popliteal aneurysms
    • Popliteal entrapment syndrome
    • Iliac artery endofibrosis
    • Arteriovenous dialysis access
    • Pediatric vascular surgery

    Dr. Audu received his medical and graduate degrees (Chemistry) from Dartmouth. He then completed a 1-year preliminary internship in General Surgery at Dartmouth, and then a 7-year Integrated Vascular Surgery Residency at the University of Michigan.

    Dr. Audu’s Research Interests Include:

    • Immunology
    • Medicinal Chemistry
    • Biophysics
    • Epigenetic enzymes

    When working with every patient, Dr. Audu’s primary goal is to help fix vascular-related ailments in a manner that meets the patient's goals and needs within the scope of his expertise and practice. He strives to provide this patient-centered care by listening to each concern, gathering appropriate clinical information, and then making appropriate recommendations for care in a compassionate, competent way.

    In his spare time, Dr. Audu enjoys reading, creative writing, cooking, spending quality family time, hiking, road biking, and soccer.

    Specialties

    Patient Rating

    Rating: 5.0 out of 5
    5.0 /5
    ( out of 30 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    December 15, 2025
    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    Dr. Audu was so kind and friendly. He explained my situation thoroughly and options for moving forward. He listened to my concerns and addressed each one. I would recommend Dr. Audu to anyone needing vascular services.

    November 24, 2025
    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    Can't say enough good things about Dr Audu. He is great!

    November 03, 2025
    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    My relationship with Dr. Audu is one of the most important relationships in my life. He keeps me alive

    September 29, 2025
    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    Dr Audu was very confident and very direct with his thoughts and explained very cleary as to why he felt as he did. Drew diagrams so i was 100% informed and new exactly what he was saying.

    July 12, 2025
    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    Professional, courteous, good listener, offered options.

    June 29, 2025
    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    Dr Audu has to be one of the VERY, VERYBEST!!

    June 23, 2025
    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    He was very nice, courteous, knowledgeable and actually listened to me and answered my questions.

    June 02, 2025
    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    Very personable, patient, and caring. Felt safe and heard. Great surgeon.

    May 05, 2025
    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    Very honest and straightforward. Listened to my concerns and gave his honest opinion on how to proceed from this moment forward. Much appreciated.

  • Christopher Audu MD, PhD, is an integrated residency-trained, adult and pediatric surgeon-scientist specializing in vascular surgery, medicinal chemistry, biophysical chemistry, immunology, and drug development as it relates to vascular disease and pathophysiology.

    Dr. Audu’s Clinical and Surgical Specialties Include:

    • Cerebrovascular disease
    • Upper extremity arterial and venous disease
    • Aortic pathology
    • Visceral artery disease
    • Aortoiliac occlusive disease
    • Peripheral arterial disease
    • Popliteal aneurysms
    • Popliteal entrapment syndrome
    • Iliac artery endofibrosis
    • Arteriovenous dialysis access
    • Pediatric vascular surgery

    Dr. Audu received his medical and graduate degrees (Chemistry) from Dartmouth. He then completed a 1-year preliminary internship in General Surgery at Dartmouth, and then a 7-year Integrated Vascular Surgery Residency at the University of Michigan.

    Dr. Audu’s Research Interests Include:

    • Immunology
    • Medicinal Chemistry
    • Biophysics
    • Epigenetic enzymes

    When working with every patient, Dr. Audu’s primary goal is to help fix vascular-related ailments in a manner that meets the patient's goals and needs within the scope of his expertise and practice. He strives to provide this patient-centered care by listening to each concern, gathering appropriate clinical information, and then making appropriate recommendations for care in a compassionate, competent way.

    In his spare time, Dr. Audu enjoys reading, creative writing, cooking, spending quality family time, hiking, road biking, and soccer.

    Board Certification and Academic Information

    Academic Departments Surgery -Assistant Professor
    Medicinal Chemistry -Adjunct Assistant Professor
    Academic Divisions Vascular Surgery

    Education history

    Residency Integrated Vascular Surgery - University of Michigan Resident
    Residency General Surgery - Dartmouth Hitchcock Medical Center Preliminary Resident
    Doctoral Training Chemistry - Dartmouth College Ph.D.
    Professional Medical Medicine - Geisel School of Medicine at Dartmouth M.D.
    Undergraduate Major: Chemistry; Minor: Mathematics - Purdue University B.Sc.
    Undergraduate Religious Education - Crossroads Bible College A.A.

    Selected Publications

    Journal Article

    1. Santosa KB, Kayward L, Matusko N, Jagsi R, Audu CO, Kwakye G, Waljee JF, Sandhu G (2021). Incivility, Work Withdrawal, and Organizational Commitment Among US Surgeons. Ann Surg, 277(3), 416-422. (Read full publication)
    2. Sharma SB, Melvin WJ, Audu CO, Bame M, Rhoads N, Wu W, Kanthi Y, Knight JS, Adili R, Holinstat MA, Wakefield TW, Henke PK, Moore BB, Gallagher KA, Obi AT (2022). The histone methyltransferase MLL1/KMT2A in monocytes drives coronavirus-associated coagulopathy and inflammation. Blood, 141(7), 725-742. (Read full publication)
    3. Audu CO, Melvin WJ, Joshi AD, Wolf SJ, Moon JY, Davis FM, Barrett EC, Mangum KD, Deng H, Xing X, Wasikowski R, Tsoi LC, Sharma SB, Bauer TM, Shadiow J, Corriere MA, Obi AT, Kunkel SL, Levi B, Moore BB, Gudjonsson JE, Smith AM, Gallagher KA (2022). Macrophage-specific inhibition of the histone demethylase JMJD3 decreases STING and pathologic inflammation in diabetic wound repair. Cell Mol Immunol, 19(11), 1251-1262. (Read full publication)
    4. Wolf SJ, Audu CO, Joshi A, denDekker A, Melvin WJ, Davis FM, Xing X, Wasikowski R, Tsoi LC, Kunkel SL, Gudjonsson JE, ORiordan MX, Kahlenberg JM, Gallagher KA (2022). IFN-κ is critical for normal wound repair and is decreased in diabetic wounds. JCI Insight, 7(9). (Read full publication)
    5. Deng H, Konopka CJ, Prabhu S, Sarkar S, Medina NG, Fayyaz M, Arogundade OH, Vidana Gamage HE, Shahoei SH, Nall D, Youn Y, Dobrucka IT, Audu CO, Joshi A, Melvin WJ, Gallagher KA, Selvin PR, Nelson ER, Dobrucki LW, Swanson KS, Smith AM (2022). Dextran-Mimetic Quantum Dots for Multimodal Macrophage Imaging In Vivo, Ex Vivo, and In Situ. ACS Nano, 16(2), 1999-2012. (Read full publication)
    6. Audu CO, Dardik A (2021). Nutrition in the management of peripheral arterial disease: should we pay more attention to what our patients eat? JVS Vasc Sci, 3, 15-16. (Read full publication)
    7. Melvin WJ, Audu CO, Davis FM, Sharma SB, Joshi A, DenDekker A, Wolf S, Barrett E, Mangum K, Zhou X, Bame M, Ruan A, Obi A, Kunkel SL, Moore BB, Gallagher KA (2021). Coronavirus induces diabetic macrophage-mediated inflammation via SETDB2. Proc Natl Acad Sci U S A, 118(38). (Read full publication)
    8. Davis FM, Tsoi LC, Melvin WJ, denDekker A, Wasikowski R, Joshi AD, Wolf S, Obi AT, Billi AC, Xing X, Audu C, Moore BB, Kunkel SL, Daugherty A, Lu HS, Gudjonsson JE, Gallagher KA (2020). Inhibition of macrophage histone demethylase JMJD3 protects against abdominal aortic aneurysms. J Exp Med, 218(6). (Read full publication)
    9. Kemp MT, Rivard SJ, Anderson S, Audu CO, Barrett M, Fry BT, Lane M, Vu JV, Young BAC, Englesbe M, Sandhu G, Coleman DM (2020). Trainee Wellness and Safety in the Context of COVID-19: The Experience of One Institution. Acad Med, 96(5), 655-660. (Read full publication)
    10. Davis FM, denDekker A, Joshi AD, Wolf SJ, Audu C, Melvin WJ, Mangum K, Riordan MO, Kunkel SL, Gallagher KA (2020). Palmitate-TLR4 signaling regulates the histone demethylase, JMJD3, in macrophages and impairs diabetic wound healing. Eur J Immunol, 50(12), 1929-1940. (Read full publication)
    11. Davis FM, Tsoi LC, Wasikowski R, denDekker A, Joshi A, Wilke C, Deng H, Wolf S, Obi A, Huang S, Billi AC, Robinson S, Lipinski J, Melvin WJ, Audu CO, Weidinger S, Kunkel SL, Smith A, Gudjonsson JE, Moore BB, Gallagher KA (2020). Epigenetic regulation of the PGE2 pathway modulates macrophage phenotype in normal and pathologic wound repair. JCI Insight, 5(17). (Read full publication)
    12. Davis FM, denDekker A, Kimball A, Joshi AD, El Azzouny M, Wolf SJ, Obi AT, Lipinski J, Gudjonsson JE, Xing X, Plazyo O, Audu C, Melvin WJ, Singer K, Henke PK, Moore BB, Burant C, Kunkel SL, Gallagher KA (2020). Epigenetic Regulation of TLR4 in Diabetic Macrophages Modulates Immunometabolism and Wound Repair. J Immunol, 204(9), 2503-2513. (Read full publication)
    13. Audu CO, Coleman DM (2019). Prioritizing personal well-being during vascular surgery training. Semin Vasc Surg, 32(1-2), 23-26. (Read full publication)
    14. Audu CO, Columbo JA, Sun SJ, Perri JL, Goodney PP, Stone DH, Nolan BW, Suckow BD (2018). Variation in timing and type of groin wound complications highlights the need for uniform reporting standards. J Vasc Surg, 69(2), 532-543. (Read full publication)
    15. Audu CO, Boniakowski AE, Robinson S, Dasika NL, Wakefield T, Coleman DM (2016). Internal iliac venous aneurysm associated with pelvic venous insufficiency. J Vasc Surg Venous Lymphat Disord, 5(2), 257-260. (Read full publication)
    16. Guo B, Audu CO, Cochran JC, Mierke DF, Pellegrini M (2014). Protein engineering of the N-terminus of NEMO: structure stabilization and rescue of IKKβ binding. Biochemistry, 53(43), 6776-85. (Read full publication)
    17. Audu CO, Plati JJ, Pellegrini M, Mierke DF (2014). Engineering a soluble parathyroid hormone GPCR mimetic. Proteins, 82(7), 1370-5. (Read full publication)
    18. Audu CO, Cochran JC, Pellegrini M, Mierke DF (2013). Recombinant production of TEV cleaved human parathyroid hormone. J Pept Sci, 19(8), 504-10. (Read full publication)
    19. Audu CO, OHara B, Pellegrini M, Wang L, Atwood WJ, Mierke DF (2012). Reining in polyoma virus associated nephropathy: design and characterization of a template mimicking BK viral coat protein cellular binding. Biochemistry, 51(41), 8092-9. (Read full publication)
    20. Scott WL, Audu CO, Dage JL, Goodwin LA, Martynow JG, Platt LK, Smith JG, Strong AT, Wickizer K, Woerly EM, ODonnell MJ (2008). Distributed Drug Discovery, Part 3: using D(3) methodology to synthesize analogs of an anti-melanoma compound. J Comb Chem, 11(1), 34-43. (Read full publication)
    21. Scott WL, Alsina J, Audu CO, Babaev E, Cook L, Dage JL, Goodwin LA, Martynow JG, Matosiuk D, Royo M, Smith JG, Strong AT, Wickizer K, Woerly EM, Zhou Z, ODonnell MJ (2008). Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction. J Comb Chem, 11(1), 14-33. (Read full publication)

    Review

    1. Audu CO, Gordon AE, Obi AT, Wakefield TW, Henke PK (2019). Inflammatory biomarkers in deep venous thrombosis organization, resolution, and post-thrombotic syndrome. [Review]. J Vasc Surg Venous Lymphat Disord, 8(2), 299-305. (Read full publication)
    2. Audu CO, Wakefield TW, Coleman DM (2019). Pediatric deep venous thrombosis. [Review]. J Vasc Surg Venous Lymphat Disord, 7(3), 452-462. (Read full publication)